Roux-en-Y Gastric Bypass (RYGB) Versus Omega-Loop Gastric Bypass (OLGB) Safety and Efficacy Short-term Study

Launched by NEMOCNICE BŘECLAV, P.O. · Nov 10, 2014

Keywords

ClinConnect Summary

Introduction:

Obesity is a risk factor for Diabetes, Ischemic heart disease, Stroke, and Hypertensive heart disease, which are the 6th, 1st, 2nd, and 10th leading causes of death according to the WHO. Bariatric or Metabolic Surgery is an Efficient and reasonably Safe method for the Treatment of Severe Obesity, Type 2 Diabetes (T2DM) and Metabolic Syndrome (MS).

Existing knowledge:

Metabolic procedures, e.g. Gastric bypass, are more effective in the treatment of T2DM than predominantly "restrictive" procedures, e.g. Gastric Banding. RYGB is one of the most prevalent procedures in the worl...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Severe Obesity: BMI ≥ 40 and ≤ 50 or (BMI ≥ 35 and \< 40 and type 2 diabetes or metabolic syndrome)
• • Inadequate results of Attempts to loose weight by Conservative means
• • Ability to understand the nature of the procedure and willing to follow postoperative routine lifestyle and checkups
• • no contraindication for bariatric surgery on psychological assessment
• • no contraindication for general anesthesia
• • consent for both variants of gastric bypass surgery
• • consent to participate in a study with randomized design
• Exclusion Criteria:
• • prior bariatric surgery of any kind
• • gravidity or recent (\<1 year) labour
• • drug or alcohol abuse
• • symptomatic Gastro Esophageal Reflux Disease (GERD)
• • hiatal hernia, \> 3cm
• • esophagitis, ≥ 2. grade
• • active smoker
• • chronic renal disease, stage ≥ 3
• • patient immobility
• • surgery not covered by universal insurance in Czech rep. (i.e. international patients)